期刊文献+

阿托伐他汀 瑞舒伐他汀治疗冠心病伴高脂血症临床疗效分析 被引量:16

下载PDF
导出
摘要 目的比较阿托伐他汀、瑞舒伐他汀在治疗冠心病伴高脂血症方面的临床疗效。方法选择2009年8月—2010年10月在我院心内科住院的150例冠心病伴高脂血症患者,随机分为观察组(瑞舒伐他汀组)和对照组(阿托伐他汀组)2组,比较2组患者治疗前后总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TC)的变化。结果观察组患者TC、TG、LDL-C下降幅度比对照组更大,观察组HDL-C升高幅度较对照组大,2组比较差异显著(P<0.01)。结论阿托伐他汀、瑞舒伐他汀治疗冠心病伴高脂血症,同等剂量下,瑞舒伐他汀的调脂作用比阿托伐他汀更明显。
作者 向玉梅 汪辉
出处 《基层医学论坛》 2013年第13期1677-1678,共2页 The Medical Forum
  • 相关文献

参考文献3

二级参考文献20

共引文献31

同被引文献98

  • 1茜玛,王培军.Efficacy of coronary computed tomography angiography in detecting atherosclerotic plaque in coronary artery disease:a comparative study with optical coherence tomography[J].外科研究与新技术,2010(4):291-302. 被引量:1
  • 2Zhonghua Sun, Discipline of Medical Imaging, Department of Imaging and Applied Physics, Curtin University of Technology, Perth, Western Australia 6845, Australia.Multislice CT angiography in coronary artery disease: Technical developments, radiation dose and diagnostic value[J].World Journal of Cardiology,2010,2(10):333-343. 被引量:19
  • 3Olsson AG. Statin therapy and reductions in low-density lipoprotein cholesterol : initial clinical data on the potent new statin Rosuvastatin [J]. Am J Cardiol, 2001,87(5A) :33B-36B.
  • 4Blasetto JW, Stein EA, Brown WV, et al. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholes- terolemic patients and in special population groups [ J ]. Am J Cardi- ol, 2003,91 (5A) :3C-10C.
  • 5Hlatky M. The cost-effectiveness of rosuvastatin therapy JUPITER ( justification for the use of statins al evaluating rosuvastatin) [ J]. J 792-793. in prevention: an intervention tn- Am Coll Cardiol, 2011,57 ( 7 ).
  • 6Capurso C, Solffizzi V, D'Introno A, et al. Beyond coronary artery disease: rosuvastatin in older patients with isehemic systolic heart failure [ J ]. J Am Geriatr Soc, 2008,56 (7) : 1366-1367.
  • 7Nohara R. COSMOS (coronary atherosclemsis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese sub- jects) trial[J]. Nihon Rinsho, 2011,69(Suppl 9) :341-344.
  • 8Scheen AJ. Clinical study of the month: ASTEROID: regression of coronary atheroselemsis with rosuvastatin at a maximal daily, dose of40 mg[J]. Rev Med L(ege, 2006,61(4) :267-272.
  • 9Roth EM, Rosenson RS, Jones PH, et al. Attainment of goal/de- sirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination thera-py : a pooled analysis of controlled studies [ J ]. J Clin Lipi- dol, 2012,6(6) :534-544.
  • 10IuV S, D'iachkov VA, Seleznev EI, et al. Molecular mechanisms of effects of rosuvastatin on systemic oxidative stress and endoge- nous inflammation in patients with atherosclerosis [ J ]. Kardiologi- ia, 2008,48(8) :41-45.

引证文献16

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部